Loading…
VICKS COLD & FLU CARE DAYMED PLUS HOT DRINK is a brand name for Phenylephrine. The medicine, its uses, side effects and dosage are the same regardless of brand.
Used for: Short term symptomatic relief of mild to moderate pain, fever, nasal congestion with an expectorant effect on chesty cough, associated with colds, chills and influenza..
Verbatim from this product's MHRA label. Tap a section to expand.
Dissolve the contents of one sachet in a standard mug of hot, but not boiling, water (approx. 250ml;). Allow to cool to a drinkable temperature.
Adults, the Elderly and children aged 12 years and over:
One sachet Repeat every four hours as required, but do not exceed four doses (sachets) in any 24 hours. Do not give to children under 12 years, except on medical advice. 3). Seek medical advice if symptoms persist for more than 3 days
The frequency of occurrence of undesirable effect is usually classified as follows: Very common (> 1/10) Common (> 1/100 to < 1/10) Uncommon (> 1/1,000 to < 1/100) Rare (> 1/10,000 to < 1/1,000) Very rare (< 1/10,000) Not known (incidence cannot be assessed on the basis of the available data) Cardiac disorders: Phenylephrine may rarely be associated with tachycardia.
, thrombocytopenia, agranulocytosis, haemolytic anaemia, neutropenia, leucopenia, pancytopenia have been reported with paracetamol, but these were not necessarily causally related.
Immune system disorders:
Rare: allergic or hypersensitivity reactions with both phenylephrine and paracetamol, including skin rashes, urticaria, anaphylaxis and bronchospasm.
Nervous system disorders:
As with other sympathomimetic amines insomnia, nervousness, tremor, anxiety, restlessness, confusion, irritability and headache may rarely occur. Headache and dizziness are also known to occur rarely with Guaifenesin.
Vascular disorders:
High blood pressure with headache, vomiting and palpitations may occur rarely phenylephrine.
Gastrointestinal disorders:
Anorexia, nausea and vomiting are common with sympathomimetics and may occur with phenylephrine. Gastrointestinal discomfort, nausea, vomiting and diarrhoea are the most common side effects associated with Guaifenesin, but these occur rarely.
Gastrointestinal effects of paracetamol are very rare but there have been reports of acute pancreatitis after ingestion of above normal dosage.
Hepatobiliary disorders:
Long term use of the product is not recommended. Patients should be advised not to take with other paracetamol-containing products or other products containing the same active ingredients as this preparation. They should also be advised not to take other cough, cold or decongestant products concurrently, or alcohol.
e. orally and topically (nasal, aural and eye preparations). This medicine should only be recommended if all symptoms (pain and/or fever, nasal congestion and chesty cough) are present. The hazards of overdose are greater in those with non-cirrhotic alcoholic liver disease.
5) Use with caution in patients with prostatic hypertrophy as they may be susceptible to urinary retention. Sympathomimetic-containing products should be used with great care in patients receiving phenothiazines. Use in patients with Raynaud’s phenomenon.
Ask a doctor before use if you have persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema. Care is advised in the administration of paracetamol to patients with impaired. hepatic function including those with non-cirrhotic alcoholic liver disease.
The hazards of overdose are greater in those with alcoholic liver disease. Precaution shall be observed when paracetamol is administered in patients with severe haemolytic anaemia, glucose-6-dehydrogenase deficit, dehydrated patients, and patients with chronic nutrition disorders.
, chronic alcoholism) who were treated with paracetamol at therapeutic dose for a prolonged period or a combination of paracetamol and flucloxacillin. If HAGMA due to pyroglutamic acidosis is suspected, prompt discontinuation of paracetamol and close monitoring is recommended.
The measurement of urinary 5- oxoproline may be useful to identify pyroglutamic acidosis as underlying cause of HAGMA in patients with multiple risk factors. Contains sucrose. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrose-isomaltase insufficiency should not take this medicine.
1. Hepatic or severe renal impairment Hypertension Hyperthyroidism, Diabetes, Heart disease, Narrow-angle glaucoma Porphyria Use in patients taking tricyclic antidepressants Use in patients who are currently taking or have taken monoamine oxidase inhibitors (MAOIs) within the last 2 weeks Use in patients taking beta-blocking drugs Use in patients who are currently taking other sympathomimetic drugs Children under 12 years
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Other brands of Phenylephrine in United Kingdom.
Know a brand we are missing in United Kingdom? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.
Rare: Liver function test abnormal (increase in hepatic transaminases).
Skin and subcutaneous disorders:
Hypersensitivity reactions including skin rash and urticaria may occur rarely. Very rare cases of serious skin reactions have been reported with paracetamol.
Renal and urinary disorders:
Interstitial nephritis has been reported incidentally after prolonged use of high doses of paracetamol.
Metabolism and nutrition disorders:
Frequency not known: High anion gap metabolic acidosis. 4). Pyroglutamic acidosis may occur as a consequence of low glutathione levels in these patients. Reporting of suspected adverse reactions Reporting of suspected adverse reactions after authorisation of the medicinal product is important.
It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard.
Contains sodium 157 mg per dose. To be taken into consideration by patients on a controlled sodium diet. Contains aspartame (E951) a source of phenylalanine. May be harmful for people with phenylketonuria.
+3 more